Alambatin, Alice M.
HRN: 02-24-04 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/06/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/06/2023
11/12/2023
IVT
4.5gms
Q8
Complicated UTI, DM Type2
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes